SUMMARY A commercial assay kit method for the simultaneous estimation of vitamin B12 and folate cohcentrations has been evaluated. Values derived for folate by a microbiological assay and vitamin B12 by a verified radioassay showed good correlation with the investigated method.
The clinical sensitivity of the assay for detecting deficient concentrations of vitamin B12 and folate was comparable to that of the non-commercial methods and other more definitive clinical procedures. Establishment of reference ranges, based on accepted statistical criteria, are discussed and such ranges are contrasted with those proposed by the manufacturer. The kit method is time and labour saving compared with the non-commercial methods.
For many years microbiological assays have been used as reference methods for measuring vitamin B12 and folate concentrations in blood. These methods were established as sensitive indicators of deficiency, but are subject to problems of antibiotic and antineoplastic drug interference and are also both time and labour intensive.
Radioisotope dilution assays have recently gained wide acceptance as alternative procedures, and their increased use can be attributed largely to an ease of use coupled with negligible drug interference. Some radioisotope dilution assays, however, experienced major specificity and interference problems, especially for vitamin B,2 measurements. Other shortcomings centre on inadequate evaluations and determination of appropriate reference ranges. '-3 A recent extension of radioisotope dilution assays has been the development of a method for the simultaneous determination of both vitamin B12 and folate. This latter method has the potential to be both cost and labour effective and may be a solution to the problems previously outlined. Certain aspects of commercial kits using these newer techniques Accepted for publication 14 August 1984 have been evaluated elsewhere.4 Information is limited to the assay of vitamin B,2 and includes the kit evaluated in this study.
Definitive reference methods for vitamin B,2 and folate are not available;5 most radioisotope dilution assays are judged against microbiological methods. Under these restrictions the true bias of such assays cannot be evaluated.
The purpose of this study was to address certain questions and problems associated with a commercial dual radioisotope dilution assay method. The evaluation centres on an assessment of precision and bias, the latter based on correlation with noncommercial methods and overall recovery of added vitamin. An Sample handling All specimens were allowed to stand at room temperature for about 4 h. After clot retraction, the specimens were centrifuged and the serum was removed and immediately frozen.
Reference and patient samples were stored at -20°C. Samples used in the comparison of assay methods were assayed within one month or less of initial routine assay. All samples were preservative free.
Equipment
All dispensing operations were carried out using Oxford Liquid Handling Instruments (Lancer, USA). Repetitive volume additions used in the normal range study were achieved using an Eppendorf Multipette (Eppendorf Geratebau, West Germany). Radioactive counting was carried out on the dual channel Packard Autogamma 5210 gamma counter (Packard Instrument Company Inc, USA). Calculation of results, determination of the normal reference ranges, and most statistical operations were performed by a program written for an Apple II microcomputer.
METHODS

Analytical methods
Each kit was used according to the manufacturer's instructions with two basic exceptions. Firstly, the assay tubes used were of dimensions 16mm x Evaluation of Combostat II dual radioassay 100mm in order to suit our gamma counter. Secondly, for convenience, the red cell folate procedure used a 1/20 dilution of whole blood in a 1% ascorbic acid solution, which also contained a trace of 10% Tween 80. This was the recommended procedure for the non-commercial method,6 with the determination by kit method performed on this same preparation. The use of Tween 80 was discontinued after the comparison study as the manufacturer did not require its use.
The non-commercial method for vitamin B12 determination was that of Tibbling.' Verification of this method against the microbiological assay using Euglena gracilis has been reported elsewhere.9 The non-commercial method for serum folate and red cell folate determinations was the microbiological method essentially as described by Waters and Mollin6 using a chloramphenicol resistant strain of Lactobacillus casei. All determinations were performed in duplicate.
Quality control studies Short term quality control was monitored from the results of the kit control sera assayed in each run. Extended precision was ascertained after completion of the evaluation study. This was based on the assay of serum pools prepared for this purpose, which were assayed in duplicate in each run. Within run precision was based on the standard deviation (SD) of duplicates within assay for all assays. Between assay precision was based on the SD between the means for all assays. Information for 51 assays was collected using eight different kit batches.
Dilution studies Limited data were generated from patient samples with raised vitamin concentrations. Neat assay values were compared with those values obtained when samples were diluted in zero standard at 1/10 dilution.
Recovery experiments
Two serum pools were spiked with dl-N5-methyltetrahydrofolic acid and cyanocobalamin of known concentrations derived from the kit standards. The serum integrity of each spiked pool was kept relatively intact by the use of one volume of spike to four volumes of serum. Determinations were performed in quadruplicate. Recovery was calculated by subtracting the base pool value from the spiked pool assay value, expressing the difference as a percentage of the amount of vitamin added.
Comparison studies
The results generated from assay by both kit and non-commercial methods were regressed using the Evaluation of Combostat II dual radioassay The results of an extensive clinical correlation are pre-sented in Tables 5 and 6. Table 5 shows the correlation of assay results by kit method with haemoglobin concentration and mean cell volume, together with 57Co B,2 plasma absorption and urinary excretion values. No bone marrow information was available for these patients. Similar information on further cases with available bone marrow information is presented in Table 6 .
Of 31 patients with bone marrow information suggesting deficiency as outlined in the methods, 15 were deficient or borderline for any one or more than one of the vitamin B,2, folate, and red cell folate determinations. No patient showing frank megaloblastosis in the bone marrow examination had a normal result by the kit method. Of the 15 patients with abnormal 57Co B,2 plasma absorption and urinary excretion results, 15 were deficient for vitamin B,29 which represents 100% agreement.
ASSESSMENT OF COSTS, ASSAY TIME, AND LABOUR
The cost of reagents and assay tubes of a combined vitamin B12, folic acid, and red cell folate request, with each determination performed in duplicate, is about $10-84 (£7-34) for the kit method. The figure may be less if the kits are purchased on a contract basis, but it is much higher than the cost of the noncommercial methods of $2 10 (£1-42). In our laboratory, however, the non-commercial methods require two technicians whereas only one technician is needed for the kit method. This results in manpower savings of about 41 5 Ih a week. The dual radioisotope dilution assay therefore allows an extra labour resource for the laboratory or the initial hiring of fewer staff to perform the assays.
Discussion
In order to evaluate the Micromedic B,1Folate
Combostat II kit we examined the performance of the kit in relation to certain common criteria, including methods established in the area of predictive and definitive clinical assessments.
The results of assay precision show that the Combostat II kit was generally reliable and reproducible in an extended study. The inter-kit batch variation at the lower vitamin B12 concentration may reflect a problem with reagents or manufacturer quality control that may need to be further investigated. Average between and within batch CVs compare favourably with figures obtained for the same kit in another study4 and for other kits" and interlaboratory evaluations.* No discrepancies were noted for raised values on sample dilution, and overall recovery of added vitamin was roughly 100%. Comparison with our standard laboratory procedures established a highly significant correlation coefficient with only a minor negative bias for folic acid and red cell folate (Fig. 2) .
Antibiotic interference in the microbiological assay of folate was a problem noted in this evalua-*Australian Wellcome Immunoassay Quality Control Program (Wellcoine Diagnostics, Beckenham, England). Definition of the laboratory reference range is of prime importance in the implementation of any clinical assay. Important considerations are the proper selection of individuals and that the sample number is sufficiently large so that valid statistical criteria may be satisfied. While non-parametric percentile methods for establishing the reference range make no assumptions as to the nature of the underlying sample population, they are not as powerful as parametric methods, when the sample population is indeed gaussian.8 Accordingly, data were transformed to meet the requirement of a normal gaussian distribution and the reference range was based on the transformed sample set ( Table 3 ). The advantage of the latter is the greater confidence achieved at the end points of the range.8
Comparison of the manufacturer's ranges with those established above highlights the importance of determining a reference range within the laboratory. While the results of vitamin B were similar, those for folate and red cell folate differed substantially (Table 3 ). This type of disagreement does not necessarily reflect on the assay, but more so on the differences in populations based on geographic, dietary, and genetic factors. The contribution of an altered red cell folate haemolysate preparation on this disagreement is not known.
The cost of the dual radioisotope dilution assays is considerably more than that of non-commercial methods. As the radioisotope dilution assay method results in a saving in the labour requirement of our assay laboratory and allows mobilisation of resources into other areas of the laboratory, it offers a major advantage in manpower. 
